DNA polymerase θ protects leukemia cells from metabolically induced DNA damage.
Blood.
2023 May 11;141(19):2372-2389. doi: 10.1182/blood.2022018428. PubMed PMID:
36580665; PubMed Central PMCID:
PMC10273171.
Molecular classification and biomarkers of clinical outcome in breast ductal carcinoma in situ: Analysis of TBCRC 038 and RAHBT cohorts.
Cancer Cell.
2022 Dec 12;40(12):1521-1536.e7. doi: 10.1016/j.ccell.2022.10.021. Epub 2022 Nov 17. PubMed PMID:
36400020; PubMed Central PMCID:
PMC9772081.
RNA-Based Classification of Homologous Recombination Deficiency in Racially Diverse Patients with Breast Cancer.
Cancer Epidemiol Biomarkers Prev.
2022 Dec 5;31(12):2136-2147. doi: 10.1158/1055-9965.EPI-22-0590. PubMed PMID:
36129803; PubMed Central PMCID:
PMC9720427.
Corrigendum to "Diagnostic accuracy of FNA to determine HPV status in HPV-associated oropharyngeal squamous cell carcinoma" [Oral Oncol. 134 (2022) 106131].
Oral Oncol.
2022 Dec;135:106212. doi: 10.1016/j.oraloncology.2022.106212. Epub 2022 Oct 21. PubMed PMID:
36274024.
Diagnostic accuracy of FNA to determine HPV status in HPV-associated oropharyngeal squamous cell carcinoma.
Oral Oncol.
2022 Nov;134:106131. doi: 10.1016/j.oraloncology.2022.106131. Epub 2022 Sep 30. PubMed PMID:
36191480.
Tumor Cell Extrinsic Synaptogyrin 3 Expression as a Diagnostic and Prognostic Biomarker in Head and Neck Cancer.
Cancer Res Commun.
2022 Sep;2(9):987-1004. doi: 10.1158/2767-9764.crc-21-0135. Epub 2022 Sep 15. PubMed PMID:
36148399; PubMed Central PMCID:
PMC9491693.
Targeting ESR1 mutation-induced transcriptional addiction in breast cancer with BET inhibition.
JCI Insight.
2022 Sep 8;7(17). doi: 10.1172/jci.insight.151851. PubMed PMID:
35881485; PubMed Central PMCID:
PMC9536271.
Poly(ADP) ribose polymerase promotes DNA polymerase theta-mediated end joining by activation of end resection.
Nat Commun.
2022 Aug 4;13(1):4547. doi: 10.1038/s41467-022-32166-7. PubMed PMID:
35927262; PubMed Central PMCID:
PMC9352658.
A comprehensive comparison on cell-type composition inference for spatial transcriptomics data.
Brief Bioinform.
2022 Jul 18;23(4). doi: 10.1093/bib/bbac245. Review. PubMed PMID:
35753702; PubMed Central PMCID:
PMC9294426.
Detectable Postoperative Circulating Tumor Human Papillomavirus DNA and Association with Recurrence in Patients With HPV-Associated Oropharyngeal Squamous Cell Carcinoma.
Int J Radiat Oncol Biol Phys.
2022 Jul 1;113(3):530-538. doi: 10.1016/j.ijrobp.2022.02.012. Epub 2022 Feb 12. PubMed PMID:
35157995.
Dosimetric and Clinical Factors Associated With Breast Reconstruction Complications in Patients Receiving Postmastectomy Radiation.
Pract Radiat Oncol.
2022 May-Jun;12(3):e169-e176. doi: 10.1016/j.prro.2021.11.011. Epub 2021 Dec 14. PubMed PMID:
34920164.
Mechanism, cellular functions and cancer roles of polymerase-theta-mediated DNA end joining.
Nat Rev Mol Cell Biol.
2022 Feb;23(2):125-140. doi: 10.1038/s41580-021-00405-2. Epub 2021 Sep 14. Review. PubMed PMID:
34522048.
Targeting Non-homologous and Alternative End Joining Repair to Enhance Cancer Radiosensitivity.
Semin Radiat Oncol.
2022 Jan;32(1):29-41. doi: 10.1016/j.semradonc.2021.09.007. Review. PubMed PMID:
34861993.
Introduction: Progress Towards Genomically-directed Radiosensitization.
Semin Radiat Oncol.
2022 Jan;32(1):1-2. doi: 10.1016/j.semradonc.2021.09.009. PubMed PMID:
34861991.
Immune-Mediated Effects of Microplanar Radiotherapy with a Small Animal Irradiator.
Cancers (Basel).
2021 Dec 29;14(1). doi: 10.3390/cancers14010155. PubMed PMID:
35008319; PubMed Central PMCID:
PMC8750301.
Phase 1 trial of adavosertib (AZD1775) in combination with concurrent radiation and cisplatin for intermediate-risk and high-risk head and neck squamous cell carcinoma.
Cancer.
2021 Dec 1;127(23):4447-4454. doi: 10.1002/cncr.33789. Epub 2021 Aug 11. PubMed PMID:
34379792.
Prognostic and Predictive Clinical and Biological Factors in HPV Malignancies.
Semin Radiat Oncol.
2021 Oct;31(4):309-323. doi: 10.1016/j.semradonc.2021.03.008. Review. PubMed PMID:
34455986.
TP53 mutations increase radioresistance in rhabdomyosarcoma and Ewing sarcoma.
Br J Cancer.
2021 Aug;125(4):576-581. doi: 10.1038/s41416-021-01438-2. Epub 2021 May 20. PubMed PMID:
34017087; PubMed Central PMCID:
PMC8368014.
Spatially Localized Immunotherapy: A Perfect Combination With Radiation Therapy?.
Int J Radiat Oncol Biol Phys.
2021 Jun 1;110(2):507-509. doi: 10.1016/j.ijrobp.2021.02.046. PubMed PMID:
33989577.
Marker-free quantification of repair pathway utilization at Cas9-induced double-strand breaks.
Nucleic Acids Res.
2021 May 21;49(9):5095-5105. doi: 10.1093/nar/gkab299. PubMed PMID:
33963863; PubMed Central PMCID:
PMC8136827.
The Role of Intraoperative Radiation in Early-stage Breast Cancer.
Clin Breast Cancer.
2021 Apr;21(2):103-111. doi: 10.1016/j.clbc.2020.12.007. Review. PubMed PMID:
34030857.
Increasing Nonresearch-Related Industry Funding in Radiation Oncology: Cause for Concern?.
Int J Radiat Oncol Biol Phys.
2021 Jan 1;109(1):26-28. doi: 10.1016/j.ijrobp.2020.09.003. PubMed PMID:
33308695.
Decline in circulating viral and human tumor markers after resection of head and neck carcinoma.
Head Neck.
2021 Jan;43(1):27-34. doi: 10.1002/hed.26444. Epub 2020 Aug 28. PubMed PMID:
32860343.
Dual inhibition of DNA-PK and DNA polymerase theta overcomes radiation resistance induced by p53 deficiency.
NAR Cancer.
2020 Dec;2(4):zcaa038. doi: 10.1093/narcan/zcaa038. Epub 2020 Dec 21. PubMed PMID:
33385162; PubMed Central PMCID:
PMC7751686.
Proceedings of the ASTRO-RSNA Oligometastatic Disease Research Workshop.
Int J Radiat Oncol Biol Phys.
2020 Nov 1;108(3):539-545. doi: 10.1016/j.ijrobp.2020.05.018. Epub 2020 May 17. PubMed PMID:
32434040.
Optimizing Radiation Therapy to Boost Systemic Immune Responses in Breast Cancer: A Critical Review for Breast Radiation Oncologists.
Int J Radiat Oncol Biol Phys.
2020 Sep 1;108(1):227-241. doi: 10.1016/j.ijrobp.2020.05.011. Epub 2020 May 14. Review. PubMed PMID:
32417409; PubMed Central PMCID:
PMC7646202.
PIK3CA Mutation in HPV-Associated OPSCC Patients Receiving Deintensified Chemoradiation.
J Natl Cancer Inst.
2020 Aug 1;112(8):855-858. doi: 10.1093/jnci/djz224. PubMed PMID:
31747025.
BRCA1 Mutational Complementation Induces Synthetic Viability.
Mol Cell.
2020 Jun 4;78(5):951-959.e6. doi: 10.1016/j.molcel.2020.04.006. Epub 2020 Apr 30. PubMed PMID:
32359443; PubMed Central PMCID:
PMC7418109.
Mechanistic basis for microhomology identification and genome scarring by polymerase theta.
Proc Natl Acad Sci U S A.
2020 Apr 14;117(15):8476-8485. doi: 10.1073/pnas.1921791117. Epub 2020 Mar 31. PubMed PMID:
32234782; PubMed Central PMCID:
PMC7165422.
Plasma Circulating Tumor HPV DNA for the Surveillance of Cancer Recurrence in HPV-Associated Oropharyngeal Cancer.
J Clin Oncol.
2020 Apr 1;38(10):1050-1058. doi: 10.1200/JCO.19.02444. Epub 2020 Feb 4. PubMed PMID:
32017652; PubMed Central PMCID:
PMC7106982.
Use of Spiked Normalizers to More Precisely Quantify Tumor Markers and Viral Genomes by Massive Parallel Sequencing of Plasma DNA.
J Mol Diagn.
2020 Apr;22(4):437-446. doi: 10.1016/j.jmoldx.2020.01.012. Epub 2020 Feb 7. PubMed PMID:
32036092; PubMed Central PMCID:
PMC7196851.
Breast conservation therapy versus mastectomy for breast cancer.
Lancet Oncol.
2020 Apr;21(4):492-493. doi: 10.1016/S1470-2045(20)30172-8. PubMed PMID:
32240608.
B cell-Derived IL35 Drives STAT3-Dependent CD8(+) T-cell Exclusion in Pancreatic Cancer.
Cancer Immunol Res.
2020 Mar;8(3):292-308. doi: 10.1158/2326-6066.CIR-19-0349. Epub 2020 Feb 5. PubMed PMID:
32024640; PubMed Central PMCID:
PMC7056532.
Circulating Tumor DNA Biomarkers for Early Detection of Oligometastasis.
Cancer J.
2020 Mar/Apr;26(2):116-123. doi: 10.1097/PPO.0000000000000437. Review. PubMed PMID:
32205535; PubMed Central PMCID:
PMC7285872.
A P53-Independent DNA Damage Response Suppresses Oncogenic Proliferation and Genome Instability.
Cell Rep.
2020 Feb 4;30(5):1385-1399.e7. doi: 10.1016/j.celrep.2020.01.020. PubMed PMID:
32023457; PubMed Central PMCID:
PMC7361372.
Increased radiation toxicity with germline ATM variant of uncertain clinical significance.
Rep Pract Oncol Radiother.
2019 Nov-Dec;24(6):672-680. doi: 10.1016/j.rpor.2019.09.008. Epub 2019 Nov 6. PubMed PMID:
31719806; PubMed Central PMCID:
PMC6839001.
Phase II Trial of De-Intensified Chemoradiotherapy for Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma.
J Clin Oncol.
2019 Oct 10;37(29):2661-2669. doi: 10.1200/JCO.19.01007. Epub 2019 Aug 14. PubMed PMID:
31411949; PubMed Central PMCID:
PMC7010421.
Genetic determinants of cellular addiction to DNA polymerase theta.
Nat Commun.
2019 Sep 19;10(1):4286. doi: 10.1038/s41467-019-12234-1. PubMed PMID:
31537809; PubMed Central PMCID:
PMC6753077.
Rapid Clearance Profile of Plasma Circulating Tumor HPV Type 16 DNA during Chemoradiotherapy Correlates with Disease Control in HPV-Associated Oropharyngeal Cancer.
Clin Cancer Res.
2019 Aug 1;25(15):4682-4690. doi: 10.1158/1078-0432.CCR-19-0211. Epub 2019 May 14. PubMed PMID:
31088830; PubMed Central PMCID:
PMC6679766.
Long-Term Pulmonary Outcomes of a Feasibility Study of Inverse-Planned, Multibeam Intensity Modulated Radiation Therapy in Node-Positive Breast Cancer Patients Receiving Regional Nodal Irradiation.
Int J Radiat Oncol Biol Phys.
2019 Apr 1;103(5):1100-1108. doi: 10.1016/j.ijrobp.2018.11.045. Epub 2018 Nov 30. PubMed PMID:
30508620; PubMed Central PMCID:
PMC6777954.
Evidence that the human cell cycle is a series of uncoupled, memoryless phases.
Mol Syst Biol.
2019 Mar 18;15(3):e8604. doi: 10.15252/msb.20188604. PubMed PMID:
30886052; PubMed Central PMCID:
PMC6423720.
Mastectomy May Be an Inferior Oncologic Approach Compared to Breast Preservation.
Int J Radiat Oncol Biol Phys.
2019 Jan 1;103(1):78-80. doi: 10.1016/j.ijrobp.2018.07.2021. Epub 2018 Dec 12. PubMed PMID:
30563667.
Tracking plasma DNA mutation dynamics in estrogen receptor positive metastatic breast cancer with dPCR-SEQ.
NPJ Breast Cancer.
2018;4:39. doi: 10.1038/s41523-018-0093-3. eCollection 2018. PubMed PMID:
30534596; PubMed Central PMCID:
PMC6281679.
BRCA1 Mutation-Specific Responses to 53BP1 Loss-Induced Homologous Recombination and PARP Inhibitor Resistance.
Cell Rep.
2018 Oct 30;25(5):1384. doi: 10.1016/j.celrep.2018.10.009. PubMed PMID:
30380426; PubMed Central PMCID:
PMC6296467.
BRCA1 Mutation-Specific Responses to 53BP1 Loss-Induced Homologous Recombination and PARP Inhibitor Resistance.
Cell Rep.
2018 Sep 25;24(13):3513-3527.e7. doi: 10.1016/j.celrep.2018.08.086. PubMed PMID:
30257212; PubMed Central PMCID:
PMC6219632.
Integrated RNA and DNA sequencing reveals early drivers of metastatic breast cancer.
J Clin Invest.
2018 Apr 2;128(4):1371-1383. doi: 10.1172/JCI96153. Epub 2018 Feb 26. PubMed PMID:
29480819; PubMed Central PMCID:
PMC5873890.
Essential Roles for Polymerase θ-Mediated End Joining in the Repair of Chromosome Breaks.
Mol Cell.
2016 Aug 18;63(4):662-673. doi: 10.1016/j.molcel.2016.06.020. Epub 2016 Jul 21. PubMed PMID:
27453047; PubMed Central PMCID:
PMC4992412.
Helical tomotherapy for bilateral breast cancer: Clinical experience.
Breast.
2016 Aug;28:79-83. doi: 10.1016/j.breast.2016.05.004. Epub 2016 May 30. PubMed PMID:
27253152.
Taselisib (GDC-0032), a Potent β-Sparing Small Molecule Inhibitor of PI3K, Radiosensitizes Head and Neck Squamous Carcinomas Containing Activating PIK3CA Alterations.
Clin Cancer Res.
2016 Apr 15;22(8):2009-19. doi: 10.1158/1078-0432.CCR-15-2245. Epub 2015 Nov 20. PubMed PMID:
26589432; PubMed Central PMCID:
PMC4870591.
Texture analysis on parametric maps derived from dynamic contrast-enhanced magnetic resonance imaging in head and neck cancer.
World J Radiol.
2016 Jan 28;8(1):90-7. doi: 10.4329/wjr.v8.i1.90. PubMed PMID:
26834947; PubMed Central PMCID:
PMC4731352.
What would you like to do?